These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 25398420

  • 1. Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.
    Matsuo Y, Tashiro H, Yanai H, Moriya T, Katabuchi H.
    Med Mol Morphol; 2015 Sep; 48(3):146-54. PubMed ID: 25398420
    [Abstract] [Full Text] [Related]

  • 2. Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2.
    Lai CR, Hsu CY, Chen YJ, Yen MS, Chao KC, Li AF.
    J Chin Med Assoc; 2013 Nov; 76(11):629-34. PubMed ID: 23962610
    [Abstract] [Full Text] [Related]

  • 3. The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
    Heckl M, Schmoeckel E, Hertlein L, Rottmann M, Jeschke U, Mayr D.
    PLoS One; 2018 Nov; 13(2):e0192881. PubMed ID: 29451900
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.
    Ye S, Yang J, You Y, Cao D, Huang H, Wu M, Chen J, Lang J, Shen K.
    Medicine (Baltimore); 2016 Mar; 95(9):e3003. PubMed ID: 26945423
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma.
    Kajihara H, Yamada Y, Shigetomi H, Higashiura Y, Kobayashi H.
    Int J Gynecol Pathol; 2012 Jul; 31(4):304-12. PubMed ID: 22653342
    [Abstract] [Full Text] [Related]

  • 11. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W, Awadallah A, Xin W.
    Int J Clin Exp Pathol; 2012 Jul; 5(7):642-50. PubMed ID: 22977660
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, Huntsman DG, Köbel M, Lee CH.
    Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
    [Abstract] [Full Text] [Related]

  • 13. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
    Kato N, Sasou S, Motoyama T.
    Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
    [Abstract] [Full Text] [Related]

  • 14. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
    Rekhi B, Deodhar KK, Menon S, Maheshwari A, Bajpai J, Ghosh J, Shylasree ST, Gupta S.
    APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.
    Higashiguchi A, Yamada T, Susumu N, Mori T, Suzuki A, Aoki D, Sakamoto M.
    Cancer Sci; 2007 Mar; 98(3):387-91. PubMed ID: 17270029
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.
    Yamamoto S, Tsuda H, Aida S, Shimazaki H, Tamai S, Matsubara O.
    Hum Pathol; 2007 Jul; 38(7):1074-1080. PubMed ID: 17442376
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.
    Kao YC, Lin MC, Lin WC, Jeng YM, Mao TL.
    Histopathology; 2012 Nov; 61(5):760-8. PubMed ID: 22747504
    [Abstract] [Full Text] [Related]

  • 20. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma.
    Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, Futagami M, Mizukami H, Yokoyama Y, Kurman RJ, Shih IeM.
    Int J Gynecol Cancer; 2012 Oct; 22(8):1310-5. PubMed ID: 22976498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.